The Twelfth Annual UBS Global Life Sciences Conference will be held at the Grand Hyatt New York, Monday, September 20 - We

NEW YORK--(BUSINESS WIRE)-- UBS (NYSE:UBS):

WHAT:

  UBS’s Annual Global Life Sciences Conference, one of the industry’s largest, will feature presentations from executives of more than 270 companies over three days. Presenting companies include:
Actelion   DENTSPLY International   PerkinElmer, Inc.
Agilent Technologies, Inc. DiaSorin QIAGEN N.V.
Alere Inc. Dr. Reddy's Laboratories Regeneron Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc F. Hoffmann-La Roche Ltd. ResMed
Allergan, Inc. Genoptix, Inc. Shanghai Fosun Pharma Group
Amgen Inc. Genzyme Corporation Sigma-Aldrich Corporation
Baxter Gilead Sciences, Inc. Sino Biopharmaceutical Ltd.
Bayer AG H. Lundbeck A/S Sirona Dental Systems, Inc.
Biogen Idec Henry Schein, Inc. Smith & Nephew
BioMarin Pharmaceutical Inc. Human Genome Sciences, Inc. STERIS Corporation
BioMed Realty Trust, Inc. Illumina, Inc. Teva Pharmaceutical Industries Ltd.
BioMerieux SA Life Technologies Thermo Fisher Scientific
Bristol-Myers Squibb Company Medtronic Inc. Thoratec Corporation
Celera Corporation Merck & Co., Inc. United Therapeutics Corporation
Celgene Corporation Merck KGaA Vertex Pharmaceuticals
Cephalon, Inc. Meridian Bioscience, Inc. Warner Chilcott
Cepheid Mettler-Toledo International, Inc. Waters Corporation
Charles River Laboratories Myriad Genetics, Inc. West Pharmaceutical Services, Inc.
China Shineway Pharmaceutical Novo Nordisk Inc.
Crucell Novozymes A/S
Danaher Corporation Pall Corporation

*This is a partial list of presenting companies. Companies subject to change. To access the agenda, please go to www.ibb.ubs.com/Conferences.

WHY:

  The annual UBS Global Life Sciences Conference is among the largest health care investor conferences in the world. Senior executives from the leading pharmaceutical, biotechnology and medical technology companies will provide insight on the biotechnology, life sciences, medical technology and pharmaceutical fields to over 2,000 attendees.

AUDIO

WEBCAST:

Audio transmissions and the conference agenda will be available on the UBS Investment Bank website at www.ibb.ubs.com/Conferences. Audio transmissions of company presentations will be available live and by replay. Replays will begin three hours after the actual presentation time and will be available on the site for up to four weeks.

 

WHEN:

Monday, September 20 through Wednesday, September 22, 20010
 

WHERE:

The Grand Hyatt at 42nd Street by Grand Central Terminal, New York City
 

REGISTER:

Members of the media may register for the conference by contacting Doug Morris at [email protected] or (212) 882-5694.



CONTACT:

UBS
Doug Morris, 212-882-5694
[email protected]

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:   Health  Biotechnology  Pharmaceutical  Other Health  Professional Services  Finance  Research  Other Science  Science

MEDIA:

Logo
 Logo

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spinout company SpringWorks has lost president and founder Lara Sullivan, M.D., who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.